Smith & Nephew burns indication for Versajet:
This article was originally published in Clinica
The US FDA has given Smith & Nephew 510(k) market clearance to expand the use of its hydrosurgery debridement system to the treatment of burns. The Versajet device is a waterjet-powered system that enables surgeons to simultaneously grasp, cut and remove damaged tissue and contaminants precisely, without collateral tissue damage associated with current surgical treatment methods, claims the firm. It was previously cleared for removing dead tissue from a wide variety of other wounds, including chronic and acute wounds. "The expansion of Versajet's labelling provides another avenue of growth for Smith & Nephew," said Joe Woody, president of the firm's Hull, UK-based advanced wound management division.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.